XPO5_MOUSE - dbPTM
XPO5_MOUSE - PTM Information in dbPTM
Basic Information of Protein
UniProt ID XPO5_MOUSE
UniProt AC Q924C1
Protein Name Exportin-5
Gene Name Xpo5
Organism Mus musculus (Mouse).
Sequence Length 1204
Subcellular Localization Nucleus . Cytoplasm . Shuttles between the nucleus and the cytoplasm.
Protein Description Mediates the nuclear export of proteins bearing a double-stranded RNA binding domain (dsRBD) and double-stranded RNAs (cargos). XPO5 in the nucleus binds cooperatively to the RNA and to the GTPase Ran in its active GTP-bound form. Proteins containing dsRBDs can associate with this trimeric complex through the RNA. Docking of this complex to the nuclear pore complex (NPC) is mediated through binding to nucleoporins. Upon transit of a nuclear export complex into the cytoplasm, hydrolysis of Ran-GTP to Ran-GDP (induced by RANBP1 and RANGAP1, respectively) cause disassembly of the complex and release of the cargo from the export receptor. XPO5 then returns to the nuclear compartment by diffusion through the nuclear pore complex, to mediate another round of transport. The directionality of nuclear export is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. Overexpression may in some circumstances enhance RNA-mediated gene silencing (RNAi) (By similarity). Mediates nuclear export of ADAR/ADAR1 in a RanGTP-dependent manner (By similarity).; Mediates the nuclear export of micro-RNA precursors, which form short hairpins. Also mediates the nuclear export of synthetic short hairpin RNAs used for RNA interference. In some circumstances can also mediate the nuclear export of deacylated and aminoacylated tRNAs. Specifically recognizes dsRNAs that lack a 5'-overhang in a sequence-independent manner, have only a short 3'-overhang, and that have a double-stranded length of at least 15 base-pairs. Binding is dependent on Ran-GTP (By similarity)..
Protein Sequence MEMEQVNALCEELVKAVTVMMDPSSTQRYRLEALKFCEEFKEKCPICVPCGLKLAEKTQIAIVRHFGLQILEHVVKFRWNSMSRLEKVYLKNSVMELIANGTLRILEEENHIKDVLSRIVVEMIKREWPQHWPDMLMELDTLFRQGETQRELVMFILLRLAEDVVTFQTLPTQRRRDIQQTLTQNMERILNFLLNTLQENVNKYQQMKTDSSQEAEAQANCRVSVAALNTLAGYIDWVSLNHITAENCKLVETLCLLLNEQELQLGAAECLLIAVSRKGKLEDRKRLMILFGDVAMHYILSAAQTADGGGLVEKHYLFLKRLCQVLCALGNLLCALLALDANIQTPINFGMYLESFLAFTTHPSQFLRSSTHMTWGALFRHEVLSRDPALLAVIPKYLRASMTNLVKMGFPSKTDSPSCEYSRFDFDSDEDFNAFFNSSRAQHGEVVRCVCRLDPKTSFQMAAEWLKYQLSASIDTGPVNSCSTAGTGEGGFCSIFSPSYVQWEAMTFFLESVINQMFRTLDKEELPVSDGIELLQLVLNFEIKDPLVLSCVLTNVSALFPFVTYKPAFLPQVFSKLFSFVTFESVGESKAPRTRAVRNVRRHACSSINKMCRDYPDLVLPNFDMLYSHVKQLLSNELLLTQMEKCALMEALVLVSNQFKDYERQKLFLEELMAPVVNIWLSEEMCRALSDIDSFIAYVGADLKSCDPAVEDPCGLNRARMSFCVYSILGVMRRTSWPSDLEEAKAGGFVVGYTPSGNPIFRNPCTEQILRLLDNLLALVRTHNTLYTPEMLTKMAEPFTKALDIVESEKTAILGLPQPLLEFNDHPVYRTTLERMQRFFGILYENCYHILGKAGPSMQQDFYTVEDLASQLLGSAFVNLNNIPDFRLRSMLRVFVKPLVLFCPSEHYETLISPILGPLFTYLHMRLSQKWHVINQRSILCGEDEIAEDNPESQEMLEEQLVRMLTREAMDLIMACCVSKKTADHTAAPTADGDDEEMMATEVAPSSVVELTDLGKCLMKHEDVCTALLITAFNSLTWKDTLSCQRATTQLCWPLLKQVMSGTLLADAVTWLFTSVLKGLQMHGQHDGCMASLVHLAFQIYEALRPRYLEIRAVMEQIPEINKESLDQFDCKLLNPSLQKAADKRRKDHFKRLIAGCIGKPLGEQFRKEVHIKNLPWLFKKPKPMLETEVLDSEEGGLATIFEP
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
41UbiquitinationLKFCEEFKEKCPICV
HHHHHHHHHHCCEEC
60.59-
211PhosphorylationYQQMKTDSSQEAEAQ
HHHHCCCCHHHHHHH
38.8721082442
212PhosphorylationQQMKTDSSQEAEAQA
HHHCCCCHHHHHHHH
34.5521082442
320AcetylationEKHYLFLKRLCQVLC
HHHHHHHHHHHHHHH
35.672415579
396AcetylationALLAVIPKYLRASMT
HHHHHHHHHHHHHHH
45.88-
396UbiquitinationALLAVIPKYLRASMT
HHHHHHHHHHHHHHH
45.88-
407UbiquitinationASMTNLVKMGFPSKT
HHHHHHHHCCCCCCC
36.15-
413UbiquitinationVKMGFPSKTDSPSCE
HHCCCCCCCCCCCCC
57.50-
416PhosphorylationGFPSKTDSPSCEYSR
CCCCCCCCCCCCCCC
24.7629514104
590UbiquitinationFESVGESKAPRTRAV
HHCCCCCCCCHHHHH
59.10-
610UbiquitinationHACSSINKMCRDYPD
HHHHHHHHHHHCCCC
37.39-
735PhosphorylationILGVMRRTSWPSDLE
HHHHHHHCCCCCCHH
25.4428066266
736PhosphorylationLGVMRRTSWPSDLEE
HHHHHHCCCCCCHHH
34.8728066266
739PhosphorylationMRRTSWPSDLEEAKA
HHHCCCCCCHHHHHC
48.8728066266
966PhosphorylationEQLVRMLTREAMDLI
HHHHHHHHHHHHHHH
19.68-
979PhosphorylationLIMACCVSKKTADHT
HHHHHHCCCCCCCCC
17.96-
1137PhosphorylationDCKLLNPSLQKAADK
CHHHHCHHHHHHHHH
42.2127841257
1160AcetylationLIAGCIGKPLGEQFR
HHHHHHCCHHHHHHH
19.7022826441

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of XPO5_MOUSE !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of XPO5_MOUSE !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of XPO5_MOUSE !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of XPO5_MOUSE !!

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of XPO5_MOUSE

loading...

Related Literatures of Post-Translational Modification

TOP